BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27733010)

  • 1. Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
    Hwa YL; Shi Q; Kumar SK; Lacy MQ; Gertz MA; Kapoor P; Buadi FK; Leung N; Dingli D; Go RS; Hayman SR; Gonsalves WI; Russell S; Lust JA; Lin Y; Rajkumar SV; Dispenzieri A
    Am J Hematol; 2017 Jan; 92(1):50-55. PubMed ID: 27733010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.
    Botteri E; Munzone E; Rotmensz N; Cipolla C; De Giorgi V; Santillo B; Zanelotti A; Adamoli L; Colleoni M; Viale G; Goldhirsch A; Gandini S
    Breast Cancer Res Treat; 2013 Aug; 140(3):567-75. PubMed ID: 23912960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker and survival in patients with lung cancer: A meta-analysis.
    Lei Z; Yang W; Zuo Y
    PLoS One; 2021; 16(2):e0245773. PubMed ID: 33592015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.
    Herrera I; Pascual S; Zapater P; Carnicer F; Bellot P; María Palazón J
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1194-7. PubMed ID: 27294486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.
    Baek MH; Kim DY; Kim SO; Kim YJ; Park YH
    J Gynecol Oncol; 2018 Nov; 29(6):e82. PubMed ID: 30207092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.
    Chen Y; Lairson DR; Chan W; Du XL
    Med Oncol; 2017 Sep; 34(9):153. PubMed ID: 28776319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.
    Cui Y; Wen W; Zheng T; Li H; Gao YT; Cai H; You M; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
    Am J Epidemiol; 2019 Aug; 188(8):1512-1528. PubMed ID: 31062847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
    Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ;
    Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study.
    Oortgiesen BE; van Roon EN; Joosten P; Kibbelaar RE; Storm H; Hovenga S; van Rees B; Woolthuis G; Veeger N; de Waal EG; Hoogendoorn M
    Eur J Clin Pharmacol; 2017 Jun; 73(6):771-778. PubMed ID: 28258356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy.
    Wang H; Liao Z; Zhuang Y; Liu Y; Levy LB; Xu T; Yusuf SW; Gomez DR
    Clin Lung Cancer; 2015 Mar; 16(2):128-36. PubMed ID: 25450873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.
    Lau WC; Froehlich JB; Jewell ES; Montgomery DG; Eng KM; Shields TA; Henke PK; Eagle KA
    Ann Vasc Surg; 2013 May; 27(4):537-45. PubMed ID: 23535525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury.
    Cotton BA; Snodgrass KB; Fleming SB; Carpenter RO; Kemp CD; Arbogast PG; Morris JA
    J Trauma; 2007 Jan; 62(1):26-33; discussion 33-5. PubMed ID: 17215730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.
    Song HJ; Lee J; Kim YJ; Jung SY; Kim HJ; Choi NK; Park BJ
    Bone; 2012 Dec; 51(6):1008-15. PubMed ID: 22960238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Katz A; Maor E; Leor J; Klempfner R
    Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker use is associated with improved outcomes in adult burn patients.
    Arbabi S; Ahrns KS; Wahl WL; Hemmila MR; Wang SC; Brandt MM; Taheri PA
    J Trauma; 2004 Feb; 56(2):265-9; discussion 269-71. PubMed ID: 14960966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
    Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
    Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
    Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.